Maternal outcomes from TOLAC versus PRCD

Maternal outcome	Number of studies/subjects	Frequency of outcome
Maternal outcome	Number of studies/subjects	TOLAC (95% CI)	PRCD (95% CI)
Maternal death	12/402,883	0.004% (0.001-0.015)	0.013% (0.004-0.042)	RR 0.33, 95% CI 0.13-0.88
Uterine rupture	8/63,499	0.47% (0.28-0.77)	0.026% (0.009-0.082)	RR 20.7, 95% CI 9.8-44.0
Hysterectomy	8/402,059	0.17% (0.12-0.26)	0.28% (0.12-0.76)	NS
Hemorrhage	6/47,754	Insufficient data to evaluate	Insufficient data to evaluate	Insufficient data to evaluate
Transfusion	9/401,307	0.9% (0.4-2.0)	1.2% (0.5-2.6)	NS
Infection	22/354,060	4.6% (0.15-13.5)	3.2% (1.3-7.3)	NS
Surgical injury	4/53,282	Insufficient data to evaluate	Insufficient data to evaluate	Insufficient data to evaluate

TOLAC: trial of labor after cesarean delivery; PRCD: planned repeat cesarean delivery; RR: relative risk; NS: not significantly different.

Data from: Guise JM, Denman MA, Emeis C, et al. Vaginal birth after cesarean: New insights on maternal and neonatal outcomes. Obstet Gynecol 2010; 115:1267.

Graphic 65114 Version 15.0

خرید پکیج

Maternal outcomes from TOLAC versus PRCD